aranidipine

Known as: methyl 2-oxopropyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2012
012319962012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
1,4-dihydropyridine (DHP) Ca(2+) antagonists have recently been shown to block T-type Ca(2+) channels, which may render favorable… (More)
Is this relevant?
2008
2008
OBJECTIVE The aim of this study was to explore the pharmacokinetic (PK) and pharmacodynamic (PD) properties and safety profiles… (More)
Is this relevant?
2006
2006
A simple, sensitive and rapid high-performance liquid chromatography/negative electrospray ionization tandem mass spectrometry… (More)
Is this relevant?
2005
2005
Calcium channel blockers (CCBs) are widely used in clinical practice, and have been reported to be effective in preventing the… (More)
Is this relevant?
2000
2000
The effects of aranidipine, a novel dihydropyridine Ca(2+) channel antagonist, on membrane currents in guinea pig ventricular… (More)
Is this relevant?
2000
2000
Objective: 1,4-Dihydropyridine calcium antagonists such as nifedipine are potent vasodilators. It is now commonly agreed that the… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2000
2000
Aranidipine, a newly developed calcium antagonist, possesses unique pharmacologic characteristics in that its metabolite (M-1… (More)
Is this relevant?
1998
1998
The purpose of this study was to investigate the renal effects of aranidipine, a novel calcium channel blocker of the… (More)
Is this relevant?
1997
1997
We investigated the effects of aranidipine, a dihydropyridine-type Ca2+ channel blocker, on contractile responses to KCl and… (More)
Is this relevant?
1996
1996
Aranidipine, a novel dihydropyridine derivative, gives rise to two active metabolites, M-1(α) and M-1(β), which exhibit… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?